Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Z Gesundh Wiss ; 30(11): 2719-2727, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-34036037

RESUMO

Purpose: Two months after its first COVID-19 case, Italy counted more than 190,000 confirmed positive cases. From the beginning of April 2020, the nationwide lockdown started to show early effects by reducing the total cumulative incidence reached by the epidemic wave. Here we provide the reproduction number estimation both in space and in time from February 24 to April 24, 2020 over 2 months into the epidemic. Methods: The aim of the present work was to provide a systematical mapping of the SARS-CoV-2 transmission dynamics spread to all regions of Italy. To do so, we estimated the basic reproduction number (R 0 ), by using the maximum likelihood estimation method in the early stage of the epidemic. In addition, we determined time evolution of this parameter across the 2 months of the observational period. Finally, we linked R t , with two indices, the first representing the number of contagious people and the latter the density of susceptibiltiy to infection of people in a region as recorded on April 24, 2020. Results: Our estimates suggest a basic reproduction number averaged over all the regions of 3.29. Based on the SARS-CoV-2 transmission dynamics reported here, we gave a quantitative evaluation of the efficiency of the government measures to lower the reproduction number below 1 (control regime). We estimated that the worst-hit regions in Italy reached the control regime level (R t < 1) in about a month. Conclusion: Our work was carried out in the period between April and July,2020. We found that the mean value of time to reach the control regime across the whole country was about 31 days from February 24, 2020. Moreover, we highlighted the interplay between the reproduction number and two epidemiological/demographic indices to evaluate the "state of activity" of the epidemic, potentially helping in challenging decisions to continue, ease, or tighten restrictions. Supplementary Information: The online version contains supplementary material available at 10.1007/s10389-021-01567-1.

2.
HPB (Oxford) ; 22(1): 116-123, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31235431

RESUMO

BACKGROUND: Several studies have described a worse prognosis for right-sided colon cancer compared to left-sided. The aim of this study was to compare patterns of recurrence and survival following resection of liver metastases (LM) from right-sided (RS) versus left-sided (LS) colon cancer. METHODS: Patients undergoing resection for colon cancer LM between 2000 and 2017 were analyzed. Rectal cancer, multiple primaries and unknown location were excluded. RESULTS: Out of 995 patients, 686 fulfilled inclusion criteria (RS-LM = 322, LS-LM = 364). RS colon cancer had higher prevalence of metastatic lymph nodes (67.4% vs. 57.1%, P = 0.008). RS-LM were more often mucinous (16.8% vs. 8.5%, P = 0.001) and G3 (58.3% vs. 48.9%, P = 0.014). 451 (65.7%) patients experienced recurrence (RS-LM 68.9% vs. LS-LM 62.9%). In RS-LM group, recurrence was more often encephalic (2.3% vs. 0%, P = 0.029) and at multiple sites (34.2% vs. 23.5%, P = 0.012). The rate of re-resection was lower in RS-LM patients (27.9% vs. 37.5%, P = 0.024). Multivariate analysis showed RS-LM to have worse 5-year overall (35.8% vs. 51.2%, P = 0.002) and disease-free survival (26% vs. 43.6%, P = 0.002). CONCLUSIONS: RS-LM is associated with worse survival and aggressive recurrences, with lower chance of re-resection.


Assuntos
Neoplasias do Colo/epidemiologia , Neoplasias do Colo/patologia , Hepatectomia , Neoplasias Hepáticas/secundário , Neoplasias Hepáticas/cirurgia , Recidiva Local de Neoplasia/epidemiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias do Colo/terapia , Intervalo Livre de Doença , Feminino , Humanos , Neoplasias Hepáticas/mortalidade , Masculino , Metastasectomia , Pessoa de Meia-Idade , Estudos Retrospectivos , Taxa de Sobrevida , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA